Tripotassium dicitrato bismuthate

Chemical formula: C₁₂H₁₀BiK₃O₁₄  Molecular mass: 780.654 g/mol  PubChem compound: 118987133

Active ingredient description

Under the effect of gastric acid, a precipitate is formed from tripotassium dicitrato bismuthate, which adheres primarily to the ulcerated area and inhibits the activity of pepsin. Tripotassium dicitrato bismuthate contributes to the healing of a high percentage of gastric and duodenal ulcers.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
A02BX05 Bismuth subcitrate A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Discover more medicines within A02BX05

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 880149-29-1
DrugBank Drug: DB09275
PubChem Compound: 118987133
RxNorm Ingredient: 47181
UNII Identifier: HS813P8QPX
BISMUTH SUBCITRATE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.